LTS Therapy Systems, LLC recalls IontoPatch 80, On-the-Go Patch Therapy and 1 other product
FDA assigned 2 recall numbers to the action, one per product; all of them are listed with this filing.
LTS Therapy Systems, LLC began a medical device recall on May 22, 2025 whose reported distribution included Ohio. FDA
What the record shows
and 1 other product beginning May 22, 2025, in a medical device recall whose distribution included Ohio. The stated reason: The nonwoven pads in the device do not absorb the saline solution or any other liquid intended to be used with the device. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 63936 units. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: May 22, 2025 FDA
- Recall number: Z-2197-2025 FDA
- Recalls in this action: 2 FDA
- Recalling firm: LTS Therapy Systems, LLC FDA
- Product: IontoPatch 80, On-the-Go Patch Therapy, Model/Catalog Number: D-0077-080; The IontoPatch is an Iontophoresis… FDA
- Reason for recall: The nonwoven pads in the device do not absorb the saline solution or any other liquid intended to be used with the… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-2197-2025 |
|---|---|
| Recalls in this action | 2 |
| Recalling firm | LTS Therapy Systems, LLC |
| Product | IontoPatch 80, On-the-Go Patch Therapy, Model/Catalog Number: D-0077-080; The IontoPatch is an Iontophoresis transdermal patch. |
| Reason for recall | The nonwoven pads in the device do not absorb the saline solution or any other liquid intended to be used with the device. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 63936 units |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20250522 |
| Reported | 20250806 |
| Distribution | US Nationwide distribution in the states of Indiana, Tennessee, New York, Minnesota, New Jersey, Ohio, Kentucky, Illinois, and South Dakota. |
| Firm location | Saint Paul, MN, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.